Healthcare and Life Science
Global Mutual presses ahead with first phase of refurbishment at Riverlabs, its 440,000 sq ft life science campus in Ware
Intelligent upgrade of existing, purpose-built laboratory spaces will be available for occupation from Q3, 2025. ...
CPFT psychologist wins international award for research
Psychologist Dr Ratko Radakovic has received an international award and recognition for his outstanding research in ALS (amyotrophic lateral sclerosis), a disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control. ...
First UK pilot study into vision and hearing health comes to Cambridge
Residents of Cambridge are encouraged to join a pioneering study that will, for the first time, provide comprehensive data on the UK’s vision and hearing health. ...
Cambridge Innovation Capital launches £100m Opportunity Fund
Aviva Investors and British Patient Capital lead investment into new growth fund addressing the UK’s scale-up funding gap. ...
Over 30,000 patients treated with Versius
CMR Surgical (CMR) – the global surgical robotics company – announces that more than 30,000 surgical cases have now been completed globally using Versius, solidifying its position as the second most utilised soft-tissue surgical robot on the market. ...
AI matches the accuracy of expert radiologists to detect prostate cancer in a major multi-centre clinical study
Lucida Medical and Hampshire Hospitals NHS Foundation Trust announce the results of a 5-year collaboration. The PAIR-1 study shows that the Pi AI software, now in use in NHS and European hospitals, is the first commercial product of its kind with performance equivalent to that of expert...
Cambridge Festival showcases pioneering health research and innovations in medicine
The Cambridge Festival is returning from March 19 to April 4 with a series of events that bring together cutting-edge health research and the latest innovations in medical science. ...
The life sciences sector: a model for collaboration
In today’s interconnected world, collaboration across borders is essential for addressing global challenges. The life sciences sector offers a compelling example of how nations can work together to foster innovation and mutual benefit. ...
Mestag Therapeutics appoints Dr. Matthew Sleeman as Chief Scientific Officer
Mestag Therapeutics, a biotech company harnessing fibroblast immunology for the benefit of patients with inflammatory disease and cancer, announces that Matthew Sleeman, PhD, has been appointed Chief Scientific Officer. ...